However, I'm intrigued to see how it will work. Will it bring in conversations from third parties? If so, will this be a good thing for pharma as will any mention count as an Adverse Incident Report?
Or will it just integrate data from owned social media properties? If so, I guess it will make life easier and perhaps remove a few barriers. I'll be very interested to see if/how it brings in data from Facebook.
When I find out, I'll update this post.


0 comments:
Post a Comment